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Elucidation of cellular and gene regulatory networks (GRNs) governing organ development will accelerate
progress toward tissue replacement. Here, we have compiled reference GRNs underlying pancreas develop-
ment from data mining that integrates multiple approaches, including mutant analysis, lineage tracing, cell
purification, gene expression and enhancer analysis, and biochemical studies of gene regulation. Using
established computational tools, we integrated and represented these networks in frameworks that should
enhance understanding of the surging output of genomic-scale genetic and epigenetic studies of pancreas
development and diseases such as diabetes and pancreatic cancer. We envision similar approaches would
be useful for understanding the development of other organs.Pancreas Development and Cell Differentiation
The pancreas is an exocrine and endocrine organ. Its exocrine
functions derive from acinar cells, which produce zymogens
that aid with nutrient digestion, and from duct cells, which form
branched tubules that secrete bicarbonate and deliver zymo-
gens for activation in the duodenum. Pancreatic endocrine func-
tion derives from hormone-secreting epithelial clusters called
islets of Langerhans that include b cells, which produce insulin.
Below, we outline aspects of development relevant for our dis-
cussion of pancreas gene regulatory networks (GRNs). Pancreas
morphogenesis begins with the evagination of the embryonic
endoderm for the formation of dorsal or ventral buds whose
development is guided by distinct transcription programs (re-
viewed in Zaret, 2008). Pancreatic progenitor cells arise around
mouse embryonic day (E) 9.0, first expressing the homeodomain
transcription factor Pdx1, then expressing the basic helix-loop-
helix (bHLH) factor Ptf1a (reviewed in Seymour and Sander,
2011; Benitez et al., 2012). Early growth and branching of the
pancreatic epithelium is regulated by fibroblast growth factor
(FGF) signaling derived from the surrounding mesenchyme
tissue (Bhushan et al., 2001) for the formation of defined cellular
domains beginning after E11. This includes a ‘‘tip’’ domain con-
taining multipotent pancreatic progenitor cells harboring the
potential to self-renew or differentiate into proacinar cells and
a ‘‘trunk’’ domain harboring ‘‘bipotent’’ cells that give rise to
endocrine islet cells or exocrine ducts (reviewed in Benitez
et al., 2012). After E13, the tip domain loses its multipotency
and becomes a proacinar region that then gives rise to mature
acinar cells (Zhou et al., 2007). Additional development is
accompanied by marked branching of pancreatic epithelial cells
and islet formation.
Multipotent pancreatic progenitors express Sox9 (Seymour
et al., 2007), and, after E13.5, Sox9 expression is restricted to
bipotent trunk cells (Lynn et al., 2007; Solar et al., 2009; Kopp
et al., 2011). These bipotent epithelial cells generate duct cells
or a transient population of endocrine precursor cells expressingthe bHLH factor Neurogenin3 (Neurog3). Neurog3+ endocrine
precursors generate the principal islet endocrine cells, which
include: glucagon+ a cells, insulin+ b cells, somatostatin+ d cells,
pancreatic polypeptide+ PP cells, and a transient fetal population
expressing ghrelin called ε cells (Arnes et al., 2012). In mice,
expression of Neurog3 in the developing pancreas is transient,
detectable between E11.5 and E18, and restricted to developing
hormoneneg cells; whereas, in humans, Neurog3 expression is
maintained for many weeks during pancreas development and
readily detected in hormone+ cells (Lyttle et al., 2008; McDonald
et al., 2012). Evidence suggests Neurog3+ cells are postmitotic
(Miyatsuka et al., 2011) and that a single Neurog3+ cell gives
rise to a single type of hormone+ islet cell (termed ‘‘unipotency’’)
( Desgraz and Herrera, 2009). Thus, pancreas development and
cell differentiation may be viewed as a series of morphological
and cellular ‘‘transitions’’ that generate several distinct types of
differentiated functional epithelial cells (Figure 1A). Below, we
provide a coherent set of GRNs framing these transitions.
GRNs That Control Pancreas Development
Cellular differentiation and organ morphogenesis in fetal devel-
opment are orchestrated by coordinated interactions between
diverse components, including genes linked through GRNs
(Davidson, 2006). The discovery of individual components and
their network relationships is critical for predicting and manipu-
lating the behavior of complex biological systems; GRNs provide
testable predictions that are not resolvable with more simplistic
views of gene regulation. Collectively, the interactions that make
up GRNs appear visually complex but, at their heart, are simpler
building blocks called ‘‘canonical subcircuits’’ or ‘‘network
motifs’’ (Davidson, 2006; Alon, 2007) (Figure 1B). These smaller
circuits generally consist of two or three nodes and are defined
by their unique topologies of positive or negative interactions
(see below), which accomplish specialized developmental pro-
grams, or tasks. Establishment of the animal body plan is a result
of the hierarchical and modular use of these subcircuits, whoseDevelopmental Cell 25, April 15, 2013 ª2013 Elsevier Inc. 5
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Figure 1. Pancreas Cell Lineage and Gene Regulatory Motifs in Development
(A) A current lineage model of pancreatic cell differentiation. Key factors that mark each lineage include: Foxa2 (definitive endoderm); Pdx1, Ptf1a, Sox9, and
Nkx6.1 (multipotent progenitor); Nkx6.1 and Sox9 (bipotent progenitor); Ptf1a (proacinar and acinar cell); Neurog3 (endocrine progenitor); Sox9 (duct cell);
NFATc1 and Ins (b cells); and Arx and Gcg (a cell).
(B) Subcircuits of a pancreas gene regulatory network representing canonical network motifs.
(C) A pancreatic progenitor gene regulatory network. Pink nodes represent transcription factors, yellow nodes represent effector genes, black lines represent a
positive or inductive relation, red lines represent a negative or inhibitory relation, and blue lines represent a nondirectional relation.
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Perspectivetopology has been selected and conserved through the evolu-
tion of different species. Our aim is to highlight pancreas devel-
opment from the perspective of network architecture and
discuss the implications for studies of tissue regeneration and
cellular reprogramming.6 Developmental Cell 25, April 15, 2013 ª2013 Elsevier Inc.To compile regulatory networks of mouse pancreas develop-
ment, we manually curated interactions by data and literature
mining. We focused on interactions involving transcription
factors that establish, specify, and maintain the development,
fate and function of major pancreatic cell types in the mouse
Developmental Cell
Perspective(Figure 1A). We assessed each reported interaction (network
‘‘edge’’) between a regulator gene and a target gene (network
‘‘nodes’’) and categorized these as ‘‘positive’’ if the regulator
enhanced the target expression or ‘‘negative’’ if the regulator
was reported to diminish target gene expression. A connection
by an edge simply denotes evidence for an interaction, not
necessarily a physical interaction. The type of experimental
evidence reported for each interaction, including biochemical
evidence for direct interactions between the regulator and target
gene (accompanied by the National Center for Biotechnology
Information PubMed citation number) is provided in Table S1
(available online). We displayed the network interactions using
Cytoscape (version 2.8.1) with hierarchical layout options (Shan-
non et al., 2003).
GRNs for Specifying the Pancreas Anlage and
Multipotent Pancreatic Progenitor Cells
In the initiation of pancreas development, cells derived from the
posterior foregut endoderm commit to form the pancreatic
anlage. How is this anlage selected? Prior studies implicate
signaling mediated by FGF, TGF-b and other factors (Deutsch
et al., 2001; Bort et al., 2004) as well as chromatin regulation
by Ezh2 and histone acetyltransferase p300 (Xu et al., 2011).
However, additional studies are needed to understand the
GRN governing this early stage of pancreas development. Prior
studies suggest that the coexpression of Ptf1a and Pdx1 may
subsequently commit the gut endoderm to a pancreatic fate
(Afelik et al., 2006; Wiebe et al., 2007), perhaps through a ‘‘coin-
cidence detection’’ mechanism inwhich the cells of the prospec-
tive pancreatic anlage need to receive two different input signals
simultaneously in order to define a new regulatory state. Once
established, this new regulatory state is stabilized by positive
feedback circuitries that involve both Ptf1a autoregulation and
direct Ptf1a induction of Pdx1 expression in pancreatic progen-
itor cells (Wiebe et al., 2007; Masui et al., 2008). Deficiency of
either factor leads to severe pancreas malformations, including
agenesis in humans (Stoffers et al., 1997; Sellick et al., 2004).
Likewise, loss of Hnf1b (Haumaitre et al., 2006), Mnx1 (also
called Hb9 or Hlxb9) (Harrison et al., 1999; Li et al., 1999),
Gata4, and Gata6 (Lango Allen et al., 2012; Xuan et al., 2012)
also leads to partial or complete pancreas agenesis. Gata4,
Foxa2, and Pdx1 might operate in a coherent feedforward loop
(Figures 1B and 1C) with so-called ‘‘AND logic’’ (Alon, 2007).
The coherent feedforward loop feature in developmental net-
works may enhance the generation of a coordinated pulse of
gene expression specifying the competent late embryonic endo-
derm toward a pancreatic fate. We speculate that a requirement
for rapid diversification of gastrointestinal tract epithelium in the
latter half of development in mice (10 days) may have selected
for this feature. Retinoic acid signaling pathwaysmost likely rein-
force this loop (Martı´n et al., 2005).
Following the commitment of the dorsal and ventral endoderm
to a pancreatic fate, self-renewing multipotent progenitor cells
expressing Ptf1a, Pdx1, Sox9, Hnf6, and Nkx6.1 emerge around
E11.5 (Figure 1C) (Lynn et al., 2007; Seymour et al., 2007). Prior
studies (Stanger et al., 2007; Zhou et al., 2007; S.K.K. and T.
Sugiyama, unpublished data) suggest that these multipotent
cells represent a transient population ‘‘depleted’’ by E14. In a
current lineage model (Figure 1A), multipotent progenitors canself-renew or differentiate to form exocrine or endocrine progen-
itors. Analysis of GRN features in progenitor cells, such as Ptf1a
autoregulation in a feedforward loop, suggests mechanisms for
re-enforcing and sustaining proliferation and multipotency in
this progenitor cell population. The natural transience of multipo-
tent population in the fetal pancreas may reflect cell-intrinsic
or -nonautonomous mechanisms (or both). For example, the
GRN of these progenitors contains several transcription factor
cascades that produce a sequential activation of factors (Fig-
ure 1B). In other developing organs, this regulatory logic gener-
ates differentiated cells with increasingly restricted potential.
GRNs Controlling Pancreatic Progenitor Cell
Differentiation
Other than self-renewal, Sox9+ Pdx1+ Ptf1a+ Nkx6+ multipotent
progenitor cells appear to have two principal fate choices: (1)
differentiation to immature exocrine acinar (proacinar) cells
expressing Ptf1a and Rpbj or (2) differentiation into bipotent
Nkx6.1+ cells that generate exocrine duct cells expressing
Sox9 or generate endocrine progenitor cells expressing Neurog3
(Figure 1A) (Iype et al., 2004; Masui et al., 2008). Incisive analysis
by Schaffer et al. (2010) has revealed that a modified double-
negative feedback loop between Ptf1a and Nkx6.1 and Nkx6.2
(Figures 1B and 1C) regulates the differentiation of multipotent
pancreatic progenitors to one of these two fates. In their model,
which is based on gain- and loss-of-function studies, Ptf1a
induces a proacinar cell program, whereas the Nkx6.1 and
Nkx6.2 factors specify progenitors to an alternate fate that
engenders Sox9+ Hnf1b+ bipotential cells with the capacity to
produce duct and endocrine islet progeny. The action of a regu-
lated double-negative feedback loop at this stage results in the
mutually exclusive expression of Ptf1a and Nkx6.1 and Nkx6.2
and defines the boundaries of these two spatial domains (David-
son, 2010).
Reciprocal repression appears to be a general mechanism to
regulate and stabilize lineage commitment choices in a variety of
tissues (Briscoe et al., 2000). Thus, the Ptf1a-Nkx6 bistable
network structure in pancreatic progenitor cells may ensure
that—once initiated—cell fate is ‘‘locked’’ into a transcriptional
state that promotes the establishment of chromatin-mediated
cellular memory. Many aspects of this model warrant further
investigation. For example, Ptf1a is thought to function princi-
pally in transcriptional activator complexes; however, it is
possible that the PTF1 complex might interact with yet unidenti-
fied corepressor proteins. Recent studies modeling pancreas
development with embryonic stem cell culture systems suggest
that the Nkx6-Ptf1a motif may be regulated by extracellular
signaling, including TGF-b pathways (Micallef et al., 2012; Guo
et al., 2013). In proacinar cells, Ptf1a cooperates with Rbpj, the
vertebrate ortholog of the Suppressor of Hairless gene. Ptf1a
and Rbpj function in a complex to induce expression of Rbpjl,
the constitutively active, pancreas-restricted paralog of Rbpj.
As acinar cells mature, Rbpjl replaces Rbpj in the PTF1 complex
and also associates with the promoters of other acinar-specific
genes, including those genes encoding exocrine digestive en-
zymes (Beres et al., 2006; Fujikura et al., 2007; Masui et al.,
2008). Thus, acinar cell maturation is regulated by a positive
feedforward loop governed by a dynamic Ptf1a transcriptional
complex (Figure 2). There are intensive efforts underway to useDevelopmental Cell 25, April 15, 2013 ª2013 Elsevier Inc. 7
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Figure 2. Gene Regulatory Network of
Differentiating Acinar Cells
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Perspectivechromatin immunoprecipitation-based approaches to identify
Ptf1a-associated genetic targets in pancreatic progenitors and
proacinar and acinar cells (Thompson et al., 2012). These
—and related efforts to identify cofactors in Ptf1a transcription
factor complexes —should eventually reveal the regulatory logic
for producing and maintaining acinar cells and shed light on the
GRN features related to pancreatic progenitor regulation by
Ptf1a.
GRNs Governing the Transition to Pancreatic Endocrine
Progenitor Cells
A crucial transition in pancreas development is the differentiation
of bipotent Sox9+ Nkx6.1+ cells to generate ducts and Neurog3+
endocrine progenitors. One critical component of this fate
choice appears to be the level of Neurog3 expression. Recent
studies suggest that Neurog3 expression must surpass a
threshold in order to commit progenitors to an endocrine fate
(Wang et al., 2010; Magenheim et al., 2011). Remarkably, these
studies show that the development of Neurog3-expressing cells
toward an endocrine fate is reversible. For example, the progeny
of bipotent progenitors that initiate transcription of a null
Neurog3 allele lack Neurog3 protein but survive and remain
within the epithelium and later acquire a ductal or acinar cell
phenotype fate (Wang et al., 2010; Magenheim et al., 2011). It
should be useful to identify Neurog3 targets systematically
at different stages of pancreatic epithelial development (E11
and later) in order to elucidate the GRN mechanisms under-
lying these striking examples of in vivo fate conversion in
the pancreas. Likewise, elucidating mechanisms regulating
Neurog3 expression (for example, see Johnson et al., 2007) is
a current focus of investigation by multiple groups. Neurog3
expression may be regulated by an incoherent positive feedfor-
ward loop (Figure 1B) (Alon, 2007) in which Sox9 activates both
Neurog3 and Hes1, a repressor of Neurog3 expression (Jensen
et al., 2000). Prior studies suggest that Hes1 coordinates input
from intercellular signaling, particularly from the Notch pathway
(Apelqvist et al., 1999; Jensen et al., 2000). Recent studies also
revealed that Ptf1a controls Dll1 to restrain Neurog3 expression
(Ahnfelt-Rønne et al., 2012).
Feedforward loop regulation can promote pulsatile gene
expression and is associated with cell-fate specification in
several systems, but the features in the Neurog3 locus that8 Developmental Cell 25, April 15, 2013 ª2013 Elsevier Inc.control transient expression are poorly
understood. There is evidence sug-
gesting that Neurog3 may positively or
negatively autoregulate its own gene
expression (Smith et al., 2004; Wang
et al., 2008; Ejarque et al., 2013). Building
models that incorporate these types of
autoregulation may reveal how cis-regu-
latory elements in the Neurog3 locus
function. For example, low-affinity en-
hancers that associate with Neurog3 to
mediate repression may underlie boththe rise and fall of Neurog3 expression. Alternately, positive
autoregulatory elements could enhance initial increases of
Neurog3 expression. Precedents for such models include
studies of enhancers with distinct binding affinities for trans-
acting factors inDrosophila (Jiang and Levine, 1993; Papatsenko
and Levine, 2005).
Neurog3+ cells are postmitotic and express Cdkn1a (Miyat-
suka et al., 2011) and acquire features ofmesenchyme, including
the ability to migrate and form islets (Gouzi et al., 2011). Thus,
GRNs describing the development of pancreatic endocrine
progenitors will most likely incorporate modules governing cell-
cycle control, epithelial-mesenchymal transitions, and islet cell
specification. How unipotent endocrine progenitors commit to
specific islet cell fates also remains an open question. Prior
studies have shown that the developmental stagewhen Neurog3
is active can influence the type of endocrine cell generated
(Johansson et al., 2007). The authors suggested that Neurog3-
expressing cells transit through different ‘‘competence’’ periods
that promote the formation of a cells, followed by b cells, then
d and PP cells. The signaling-, genetic-, or chromatin-regulated
basis for this finding has not been elucidated but most likely con-
nects with elements defining a double-negative feedback loop,
which may include Neurog3, Nkx2.2, Pax4, and Arx (Figures
1B and 3) (Collombat et al., 2003, 2005, 2009; Kordowich
et al., 2011; Papizan et al., 2011), central to islet cell fate alloca-
tion. The core element in this loop is direct reciprocal repression
by the homeodomain factors Pax4 and Arx (Collombat et al.,
2003, 2005, 2009), a motif known to control andmaintain lineage
choices in development (Figure 1B). Mafb, Mafa, Isl1, and Pdx1
are also important determinants of a cell and b cell fate (Artner
et al., 2010; Hang and Stein, 2011; Yang et al., 2011), and net-
works linking the Pax4-Arx regulatory loop and these factors
are being established (Liu et al., 2011; Hunter et al., 2013). How-
ever, our understanding is far from complete. For example, a
direct reciprocal repression by Arx and Pax4 in an unmitigated
double-negative feedback loop would produce an ‘‘ON-OFF’’
state for these factors. Yet, loss of Arx or Pax4 does not lead
to complete loss of b cells or a cells (Collombat et al., 2005).
Thus, from GRN considerations, we predict the discovery of
additional regulators that modulate Arx or Pax4 expression to
control the apportioning of cell fates during islet cell differentia-
tion (Figure 1B). Given the advances of cell sorting followed by
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Perspectiveglobal chromatin and RNA analysis with small numbers of cells
and methods to assess gene function in a developmentally-rele-
vant context, we anticipate rapid expansion and understanding
of cell-specific, time-specific networks on a genome-wide scale.
GRNs Governing Pancreatic b Cell Maturation and Fate
Compared to knowledge of the genetic control of fetal pancreas
development or adult b cells (Figure 4), less is known about the
GRNs governing late fetal and postnatal pancreas development.
Once formed, islet b cells proliferate and acquire physiological
functions promoting their principal roles in nutrient sensing and
insulin secretion. Knowledge about the GRNs governing adult
b cell function (Figure 4) is dominated by studies revealing the
functions of transcription factors implicated in monogenic forms
of diabetes, called maturity onset diabetes in the young (MODY),
including Pdx1, Hnf1a, Hnf1b, Hnf4a, and Neurod1. Recent
studies show that b cell ‘‘maturation’’ and expansion are regu-
lated by the calcineurin (Cn)-NFAT pathway (Figure 5; referenced
in Heit et al., 2006, and Goodyer et al., 2012). Cn-NFAT signaling
is required for the appropriate postnatal expression of cell-cycle
regulators that promote b cell growth, including Ccnd2, Foxm1,
and Ccna2, for the expression of genes encoding MODY factors
(Figure 5) (Heit et al., 2006) and components crucial for insulin
production, processing, storage, and secretion (Goodyer et al.,
2012). The Cn-NFAT pathways also regulate ‘‘activity-depen-
dent’’ development, functional maturation, and expansion in
other tissues and cells, including neurons, muscle, bone, and
lymphocytes; thus, knowledge from GRN investigations in these
contexts may expand understanding of Cn-NFAT roles in b cell
maturation. The transcription factors Mafb, Mafa, and Glis3 are
linked to this network and also regulate postnatal development
of islet b cells (Artner et al., 2008, 2010; Kang et al., 2009). The
structure of this subcircuit can be considered a ‘‘single input
motif’’ or a ‘‘gene battery’’ (Figures 1B and 5). In these structures,Developmental Cthe regulator has a high number of outgo-
ing links and may coordinately control a
cohort of effector genes. This enables
cells to coordinate the activity of a group
of genes that function in the same or
related pathways.
Given the intensive worldwide efforts in
this area, information about GRNs con-
trolling b cell maturation in juvenile
animals will grow in the near future, pro-
moting the expansion of knowledge
about physiological and intercellular reg-
ulators of b cell growth and maturation,
such as glucose, incretins, Ca2+, and
glucokinase (Puri and Hebrok, 2010; Sey-
mour and Sander, 2011; Benitez et al.,
2012; Goodyer et al., 2012). Studies of
adult b cell fate should also inform our
understanding of b cell maturation. Like-
wise, studies of cycling adult b cellsshould demonstrate how regulatory networks change when b
cells proliferate. Do b cells, perhaps similar to proliferating hepa-
tocytes (Klochendler et al., 2012), have programs that permit
controlled dedifferentiation? If so, are the regulatory networks
that govern b cell development simply re-established? For
example, loss of insulin expression has been repeatedly ob-
served in b cells driven to proliferate in culture (Chen et al.,
2011) (Figure 5) or deficient in mechanisms that re-enforce b
cell fate (Dhawan et al., 2011). Studies of the insulin locus and
GRNs, including MODY factors governing the expression of b
cell insulin, might reveal that naturally cycling b cells also tran-
siently dedifferentiate to accommodate the requirements of
cell-cycle progression and division. This possibility is under-
scored by recent studies, including those by Talchai et al.
(2012), providing evidence for the dedifferentiation of adult islet
b cells in animal models of diabetes. The identification of
GRNs governing natural or pathological dedifferentiation in b
cells might advance efforts to convert or reprogram non-b cells
toward a b cell fate (Zhou et al., 2008). For instance, current
reprogramming protocols involve constitutive overexpression
of pancreatic factors, but GRN-guided reprogramming proto-
cols, which would mimic the dosage, combinatorial logic, and
temporal expression of normal pancreatic development, may
generate functional b cells with better efficiency.
Conclusion and Prospects
For this perspective, we compiled a set of regulatory networks
that represent the development of major pancreatic cell types
in the mouse on the basis of literature mining. However, these
networks remain far from being complete. A systematic catalog
of transcription factors and cis-regulatory information that coor-
dinates the regulation of target genes would provide essential
building blocks of GRNs. The application of genome-scale
assays to query gene expression profiles and chromatin statesell 25, April 15, 2013 ª2013 Elsevier Inc. 9
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Perspectiveof purified pancreatic cell types at distinct developmental stages
should provide an experimental strategy to expand the regu-
latory networks presented here. The insights obtained from
studying developmental GRNs can have applications that range
from building synthetic circuits in reprogrammed cells (Ruder
et al., 2011) to finding pharmacological agents with minimal
off-target effects. Despite some initial successes, cell reprog-
ramming or conversion for the generation of medically-important
cell types, such as functional pancreatic islet cells, remains rela-
tively inefficient and stochastic, most likely reflecting an igno-
rance of important regulatory interactions that exist during47
34
8
4
45
24
646
39
48
38
37
14
11
53
2816253121 35
33
17
10
9
7
Pdx1
Glut2
Pax6
Mafa
Pcsk1
CIa2CcnA2Hnf1aIrs2ChgB
NFATc1
Ccnd1 Tnfa
Mafb
Slc30a8
Nkx6.1
Nkx2.2Foxa2
Rfx6
Figure 5. Immature b Cell Gene Regulatory Network
10 Developmental Cell 25, April 15, 2013 ª2013 Elsevier Inc.pancreas development. Advances in developmental and stem
cell biology also reveal an unexpected degree of flexibility in
developing or diseased cells and the regulatory networks that
underlie the acquisition or maintenance of cell fate and physio-
logical functions. This may be particularly important for some
adult organs, including the pancreas, which may lack a dedi-
cated stem cell and, therefore, require the maintenance of cell
and tissue function through the self-renewal of differentiated
cells instead of neogenesis.
Similar approaches should be possible for studies of human
pancreas development and for building GRNs of the human19
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Perspectivepancreas. For instance, with the use of cell-surface markers and
flow cytometry, it is possible to enrich for adult human b, a,
acinar, and ductal cell populations (Dorrell et al., 2011). Expand-
ing this strategy to the human juvenile and fetal pancreas would
permit a gene expression analysis that can ultimately guide
the mapping of GRNs of the human pancreas. In addition, inte-
grating data available from the ENCODE consortium regarding
open chromatin sites, chromatin interactions, and transcription
factor motif information and from gene-centered studies, such
as enhanced yeast one-hybrid assays (Reece-Hoyes et al.,
2011), should prove fruitful for generating comprehensive
maps of GRNs. Altogether, the analysis of these networks would
provide insights beyond single-factor-centered pathways,
generate a more global view of pancreas development, and
guide regenerative therapies by presenting alternative ways to
reprogram cells into different pancreatic fates. The general
points we discussed in this perspective should be applicable
to other organ systems.SUPPLEMENTAL INFORMATION
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